Astellas Pharma Inc.
Astellas Pharma Inc. (ALPMF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALPMF · as of Jun 8, 2026
Key Statistics
Explore Astellas Pharma Inc. Data
alpmf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
alpmf competitorsALPMF
BMXXY
CHJTF
CSPCY
FMCQF
GIKLYStock Performance
Full HistoryAbout Astellas Pharma Inc.
Astellas Pharma Inc. operates as a global pharmaceutical enterprise, encompassing the development, manufacturing, distribution, and commercialization of medicinal products across international markets…
what is astellas pharma inc. · alpmf stock overview · astellas pharma inc. company profile · who is astellas pharma inc. ceo · alpmf OTC · astellas pharma inc. headquarters · astellas pharma inc. business segments
About Stock Overview & Key Data
Astellas Pharma Inc. (ALPMF) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Apr 26, 2010. As of the latest trading session, ALPMF stock price is $14.48, with a market capitalization of $25.9B. The stock has returned +45.54% over the past 12 months and +11.62% year-to-date.
In fiscal year 2026, Astellas Pharma Inc. reported revenue of $2.15T. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Astellas Pharma Inc. (ALPMF) stock price is $14.48. The stock is traded on OTC under the ticker symbol ALPMF. The 52-week range is $9.34 – $17.85.